Qamar Huma 4
4 · Ocugen, Inc. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Qamar Huma
Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2024-04-16+308,465→ 308,465 totalExercise: $1.59Exp: 2034-04-16→ Common Stock (308,465 underlying)
Footnotes (1)
- [F1]The option vests annually in equal installments over three years commencing on April 16, 2025, subject to continued service with the Issuer on the applicable vesting dates.